Background Metformin has been proposed as possibly a safer and more effective long‐term
treatment than the oral contraceptive pill (OCP) in women with polycystic ovary syndrome …

Polycystic ovary syndrome (PCOS) is a variable disorder that is characterized in adolescents
and young women by a broad spectrum of anomalies, including hyperandrogenemia, insulin …

Objective The objective of this study was to determine the levels of thrombospondin‐1 (TSP‐
1), transforming growth factor‐β1 (TGF‐β1) and nuclear factor kappaβ (NF‐κβ) in polycystic …

BACKGROUND Androgen excess is a key pathogenetic mechanism in polycystic ovary
syndrome (PCOS), although hyperinsulinism also contributes to androgen secretion …

Hyperinsulinaemic androgen excess is the most common cause of hirsutism, acne and
menstrual irregularity in adolescent girls. Here, we propose that the disorder frequently …

PCOS, a heterogeneous disorder characterized by cystic ovarian morphology, androgen
excess, and/or irregular periods, emerges during or shortly after puberty. Peri-and post …

Metformin is a widely used drug in the therapy of patients affected by diabetes mellitus.
Although some caution is needed in the very old, advanced age per se does not represent a …

Objectives. To systematically evaluate the efficacy and safety of Diane-35 for treating
polycystic ovary syndrome (PCOS) and compare it with metformin, either in combination or …

Objectives: To investigate the effects of treatment with medroxyprogesterone acetate (MPA),
10 days per month for 6 months, on lipid and carbohydrate metabolism in women with …

Objective To determine the effects of different treatment regimens on the hormonal features,
metabolic parameters, and hematologic variables in women with polycystic ovary syndrome …